Search
for
Sort by
Research 571–600 of 1000+
- New Drugs: Eculizumab
- New All Natural Shampoo Treatment for Hair Loss After Child Birth
- New onset of alopecia in a young woman with end-stage renal disease
- New Finasteride Trial Results Aim To Curb Controversy
- New frontiers in human hair follicle (neuro‐)endocrinology
- New allergens for the 21st century
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Iobenguane sulfate
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- NEW FORMULATIONS: Glatiramer acetate
- New drugs: Agalsidase alfa
- New Synthesis of Methyl 3β-Hydroxy-5-androstene-17β-carboxylate
- New York in June and hair transplants too!
- New Publications
- New Hair Transplant Organization
- New food supplement cures alopecia
- [New therapeutic aspects in non-cicatricial alopecias].
- Retinoids - new uses and new synthetic agents
- NEW ENGLAND DERMATOLOGICAL SOCIETY
- NEW ENGLAND DERMATOLOGICAL SOCIETY
- New Drugs for Leukæmia and Tumours
- NEW YORK ACADEMY OF MEDICINE, SECTION OF DERMATOLOGY AND SYPHILOLOGY
- NEW YORK ACADEMY OF MEDICINE, SECTION OF DERMATOLOGY AND SYPHILOLOGY
- NEW STRATEGIES FOR THE USE OF TOPICAL PRODUCTS IN THE TREATMENT OF ANDROGENETIC ALOPECIA
- New Nonsteroidal Molecules as Blockers of the Steroidogenic Pathway
- New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination))
- New Perspectives on the Treatment of Androgenetic Alopecia